Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
acetylsalicylic acid + sodium bicarbonate + citric acid
- Development stage
- Phase 3
- Lead developer
- Bayer
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Oral
01
Overview
This drug is a fixed-dose combination of three active ingredients: acetylsalicylic acid (aspirin), sodium bicarbonate, and citric acid. Aspirin is a non-steroidal anti-inflammatory drug (NSAID) that acts as an analgesic and antipyretic by irreversibly inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of prostaglandins involved in pain, inflammation, and fever. It also inhibits platelet aggregation by blocking thromboxane A2 production. Sodium bicarbonate is an antacid that neutralizes excess gastric acidity through a chemical reaction with stomach hydrochloric acid. Citric acid reacts with sodium bicarbonate to produce effervescence when dissolved in water, aiding palatability and further buffering stomach acidity. The combination is primarily used for the relief of minor aches and pains accompanied by heartburn or indigestion but may also be used to reduce the risk of blood clots under medical supervision[1][3][6][7]. Developed originally by Dr. Miles Medicine Company in 1931, it has been owned by Bayer since 1978[6].
- Brand names
- Alka-SeltzerAlka-Seltzer OriginalAlka-Seltzer Extra StrengthPain Relief EffervescentAlcortin A
- Other names
- aspirin, sodium bicarbonate, and citric acidaspirin-citric acid-sodium bicarbonate
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on acetylsalicylic acid + sodium bicarbonate + citric acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on acetylsalicylic acid + sodium bicarbonate + citric acid.